Unknown

Dataset Information

0

α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas.


ABSTRACT: Chordomas and chondrosarcomas are malignant mesenchymal tumours with overlapping morphological and immunohistochemical (IHC) characteristics. Our aim was to evaluate the IHC expression of α-methylacyl-CoA racemase (AMACR/P504S), β-catenin and E-cadherin in chordomas relative to chondrosarcomas and assess the utility of these markers for differential diagnosis.Archival sections of 18 chordomas, 19 chondrosarcomas and 10 mature cartilage samples were immunostained and scored for AMACR, β-catenin and E-cadherin and the relative differential capacity of each marker was calculated. In addition, AMACR mRNA level was assessed in 5 chordomas by RT-PCR and evaluated by comparative CT method.AMACR and β-catenin stained 88.9% and 94.1% of the chordomas respectively, 21.1% and 10.5% of the chondrosarcomas correspondingly and none of the mature cartilage samples. E-cadherin stained positively 82.4% of the chordomas, 36.8% of the chondrosarcomas and 42.9% of the mature cartilage cases. Both AMACR and β-catenin showed statistically significant difference between chordomas and chondrosarcomas (p < 0.001 for both), unlike E-cadherin. AMACR was detected at the mRNA level.AMACR is expressed in most of the chordomas but only in a minority of chondrosarcomas. AMACR may serve as IHC marker of chordoma with differentiating ability comparable to that of β-catenin.

SUBMITTER: Aviel-Ronen S 

PROVIDER: S-EPMC4758046 | biostudies-other | 2016 Feb

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC3375458 | biostudies-literature
| S-EPMC8254661 | biostudies-literature
| S-EPMC7590573 | biostudies-literature
| S-EPMC4600597 | biostudies-literature
| S-EPMC3567975 | biostudies-literature
| S-EPMC3051191 | biostudies-literature
| S-EPMC1222534 | biostudies-other
| S-EPMC6891009 | biostudies-literature
| S-EPMC4215266 | biostudies-literature
| S-EPMC10967716 | biostudies-literature